That means that people with diabetes, for instance, are not eligible for the program, but may be able to access the medications through other drug coverage
doi:10.1097/00006416-199409000-00008 [19] Law LAF, Sluka KA, McMullen T, Lee J, Arendt-Nielsen L, Graven-Nielsen T
Simple, practical, and built for modern routines
Novo Nordisk A/S, Denmark) is a glucagon-like peptide-1 (GLP-1) analogue, approved in numerous countries for the once weekly (OW) subcutaneous (s.c.) treatment of T2D [10, 11]
Science 179:588590
Consequently, introducing functional groups onto the staple seems to be a promising strategy, as modularized staple functionalization can be achieved through the development of two-component stapling strategies, which have become a tangible reality in recent years [39, 42, 174]